Injectable aesthetics reviews. DSM repurchases shares as part of buy-back program
THE WHAT? Royal DSM has repurchased 126,930 of its own shares in the period from 17 May 2021 up to and including 21 May 2021 at an average price of €148.27. THE DETAILS The buy-back from the global science-based company, which specialises in nutrition, health and sustainable living, is in accordance with the repurchase program announced in…